Literature DB >> 6823686

Histopathology of the brain vascular network in moyamoya disease.

M Yamashita, K Oka, K Tanaka.   

Abstract

There is an unusual vascular network at the base of the brain in patients with moyamoya disease. We detected various histologic lesions in the perforating arteries of 22 patients. Vessels showing rupture ranged from 50 to 530 microns in diameter; they were dilated, some had fibrin deposits in the wall, fragmented elastic laminae and attenuated media. Non-ruptured perforating arteries (diameter 200 to 550 microns) revealed microaneurysm formation, focal fibrin deposits and marked attenuation of the wall thickness with diminution of the elastic lamina. These changes seem to predispose to rupture of perforating arteries. Stenotic changes such as fibrous intimal thickening, collapse of the lumen and thrombosis were detected in 14 out of 22 cases. Morphometric analysis of perforating arteries indicated that arteries showing extreme degrees of stenosis or dilatation were more frequent in the patients with moyamoya disease than in the control cases. Dilative arteries were more frequent in the young patients and stenotic vessels were, in contrast, less frequent in the young patients.

Entities:  

Mesh:

Year:  1983        PMID: 6823686     DOI: 10.1161/01.str.14.1.50

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  47 in total

1.  Large-Vessel Vasculopathy in Children With Sickle Cell Disease: A Magnetic Resonance Imaging Study of Infarct Topography and Focal Atrophy.

Authors:  Kristin P Guilliams; Melanie E Fields; Dustin K Ragan; Yasheng Chen; Cihat Eldeniz; Monica L Hulbert; Michael M Binkley; James N Rhodes; Joshua S Shimony; Robert C McKinstry; Katie D Vo; Hongyu An; Jin-Moo Lee; Andria L Ford
Journal:  Pediatr Neurol       Date:  2016-12-07       Impact factor: 3.372

2.  Loss of α1β1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia.

Authors:  Dominique Hervé; Anne Philippi; Reda Belbouab; Michel Zerah; Stéphane Chabrier; Sophie Collardeau-Frachon; Francoise Bergametti; Aurore Essongue; Eliane Berrou; Valérie Krivosic; Christian Sainte-Rose; Emmanuel Houdart; Frédéric Adam; Kareen Billiemaz; Marilyne Lebret; Sabine Roman; Sandrine Passemard; Gwenola Boulday; Audrey Delaforge; Stéphanie Guey; Xavier Dray; Hugues Chabriat; Peter Brouckaert; Maryjke Bryckaert; Elisabeth Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2014-02-27       Impact factor: 11.025

3.  Champagne bottle neck sign in a patient with Moyamoya syndrome.

Authors:  Takafumi Shimogawa; Takato Morioka; Tetsuro Sayama; Takeshi Hamamura; Chiharu Yasuda; Shuji Arakawa
Journal:  World J Clin Cases       Date:  2014-09-16       Impact factor: 1.337

4.  Assessment of the cortical artery using computed tomography angiography for bypass surgery in moyamoya disease.

Authors:  Hime Suzuki; Takeshi Mikami; Katsuya Komatsu; Shouhei Noshiro; Kei Miyata; Toru Hirano; Masahiko Wanibuchi; Nobuhiro Mikuni
Journal:  Neurosurg Rev       Date:  2016-07-30       Impact factor: 3.042

5.  Moyamoya disease in adults: the role of cerebral revascularization.

Authors:  Gregory J Zipfel; Douglas J Fox; Dennis J Rivet
Journal:  Skull Base       Date:  2005-02

6.  Cardiac manifestations in a western moyamoya disease population: a single-center descriptive study and review.

Authors:  Anthony S Larson; Luis Savastano; James Klaas; Giuseppe Lanzino
Journal:  Neurosurg Rev       Date:  2020-06-07       Impact factor: 3.042

7.  Location-based treatment of intracranial aneurysms in moyamoya disease: a systematic review and descriptive analysis.

Authors:  Anthony S Larson; Lorenzo Rinaldo; Waleed Brinjikji; Giuseppe Lanzino
Journal:  Neurosurg Rev       Date:  2020-05-08       Impact factor: 3.042

8.  Endovascular treatment of a ruptured flow aneurysm of the heubner artery as part of a moyamoya collateral network in a young patient with an occluded middle cerebral artery.

Authors:  Ratna S Bechan; Willem Jan van Rooij
Journal:  Interv Neuroradiol       Date:  2014-12-05       Impact factor: 1.610

9.  The roles of methylenetetrahydrofolate reductase 677C>T and 1298A>C polymorphisms in moyamoya disease patients.

Authors:  Young Seok Park; Young Joo Jeon; Hyun Seok Kim; In Bo Han; Joong-Uhn Choi; Dong-Seok Kim; Nam Keun Kim
Journal:  Childs Nerv Syst       Date:  2014-08-07       Impact factor: 1.475

10.  Identification of novel biomarker candidates by proteomic analysis of cerebrospinal fluid from patients with moyamoya disease using SELDI-TOF-MS.

Authors:  Yoshio Araki; Kazuhiro Yoshikawa; Sho Okamoto; Masaki Sumitomo; Mikio Maruwaka; Toshihiko Wakabayashi
Journal:  BMC Neurol       Date:  2010-11-08       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.